F17I (p.Phe17Ile) variant of SCN2A (Q99250)

F17I (p.Phe17Ile) in SCN2A (Q99250) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; moderate impact. The available variant effect predictions contribute to a CATVariant prioritization score of 0.93 / 1. The record also includes structural context.

F17I (p.Phe17Ile) variant details